After a volatile trading session, US stock futures remain steady.
US equity-index futures were steady on Wednesday after a tumultuous trading session across all three major indexes, as markets continue to measure investor mood in the face of growing COVID-19 cases.
The Dow Jones Industrial Average was unchanged, while the S&P 500 was up only 0.02 % a day after setting a new high. Nasdaq futures increased by 0.1 % .
Oil prices were down, with the front-month global benchmark Brent crude falling 0.3 % and West Texas Intermediate crude falling 0.5 % .
The trade imbalance is estimated to have increased to $88.1 billion in November from $82.9 billion in October, according to figures from the US Bureau of Economic Analysis.
The National Association of Realtors’ pending home sales index is expected to have improved by 0.8 % on a monthly basis.
In other global markets, Japan’s Nikkei closed down 0.6 % on Wednesday. Hong Kong’s Hang Seng fell 0.9 % , while China’s Shanghai Composite fell 0.9 % . In afternoon trade, the Xetra DAX in Germany was down 0.6 % , the CAC 40 in France was down 0.2 % , and the FTSE 100 was up 0.8 % .
On the plus side, NRX Pharmaceuticals (NRXP) gained 14 % after filing a request for FDA breakthrough therapy designation for Zyesami as a treatment for certain high-risk COVID-19 patients. Victoria’s Secret & Co. (VSCO) surged 8% after launching a $250 million stock repurchase program. Calix (CALX) gained 9% after being included to the S&P MidCap 400.
Applied UV (AUVI) fell 21 % after the business priced a $8 million underwritten public offering. Fuel Cell Energy (FCEL) dropped nearly 13% after announcing a reduction in fiscal Q4 sales. Cal-Maine (CALM) fell 6% in the second quarter due to inconsistent performance.